nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.684	1	CbGbCtD
Zoledronate—GGPS1—nephron tubule—focal segmental glomerulosclerosis	0.0186	0.189	CbGeAlD
Zoledronate—GGPS1—kidney—focal segmental glomerulosclerosis	0.0163	0.166	CbGeAlD
Zoledronate—GGPS1—cortex of kidney—focal segmental glomerulosclerosis	0.0159	0.162	CbGeAlD
Zoledronate—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00862	0.0397	CcSEcCtD
Zoledronate—FDPS—nephron tubule—focal segmental glomerulosclerosis	0.00857	0.0872	CbGeAlD
Zoledronate—CA12—kidney—focal segmental glomerulosclerosis	0.00762	0.0775	CbGeAlD
Zoledronate—FDPS—kidney—focal segmental glomerulosclerosis	0.00753	0.0766	CbGeAlD
Zoledronate—FDPS—cortex of kidney—focal segmental glomerulosclerosis	0.00734	0.0746	CbGeAlD
Zoledronate—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00615	0.0283	CcSEcCtD
Zoledronate—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00607	0.0279	CcSEcCtD
Zoledronate—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.0263	CcSEcCtD
Zoledronate—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.0237	CcSEcCtD
Zoledronate—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0213	CcSEcCtD
Zoledronate—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00459	0.0211	CcSEcCtD
Zoledronate—CA2—nephron tubule—focal segmental glomerulosclerosis	0.00445	0.0453	CbGeAlD
Zoledronate—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.00426	0.0433	CbGeAlD
Zoledronate—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.0194	CcSEcCtD
Zoledronate—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0192	CcSEcCtD
Zoledronate—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.0185	CcSEcCtD
Zoledronate—CA2—kidney—focal segmental glomerulosclerosis	0.00391	0.0398	CbGeAlD
Zoledronate—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.0177	CcSEcCtD
Zoledronate—CA2—cortex of kidney—focal segmental glomerulosclerosis	0.00381	0.0387	CbGeAlD
Zoledronate—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.0168	CcSEcCtD
Zoledronate—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.0158	CcSEcCtD
Zoledronate—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.0148	CcSEcCtD
Zoledronate—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0147	CcSEcCtD
Zoledronate—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.0144	CcSEcCtD
Zoledronate—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.0142	CcSEcCtD
Zoledronate—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.0138	CcSEcCtD
Zoledronate—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.0136	CcSEcCtD
Zoledronate—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.0121	CcSEcCtD
Zoledronate—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.0115	CcSEcCtD
Zoledronate—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0113	CcSEcCtD
Zoledronate—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0112	CcSEcCtD
Zoledronate—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.011	CcSEcCtD
Zoledronate—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0103	CcSEcCtD
Zoledronate—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.01	CcSEcCtD
Zoledronate—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00986	CcSEcCtD
Zoledronate—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00969	CcSEcCtD
Zoledronate—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00966	CcSEcCtD
Zoledronate—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00953	CcSEcCtD
Zoledronate—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00946	CcSEcCtD
Zoledronate—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00931	CcSEcCtD
Zoledronate—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00922	CcSEcCtD
Zoledronate—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00907	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.0088	CcSEcCtD
Zoledronate—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00874	CcSEcCtD
Zoledronate—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00861	CcSEcCtD
Zoledronate—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00856	CcSEcCtD
Zoledronate—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00844	CcSEcCtD
Zoledronate—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00844	CcSEcCtD
Zoledronate—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00841	CcSEcCtD
Zoledronate—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0083	CcSEcCtD
Zoledronate—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00823	CcSEcCtD
Zoledronate—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.0082	CcSEcCtD
Zoledronate—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.0082	CcSEcCtD
Zoledronate—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00805	CcSEcCtD
Zoledronate—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00754	CcSEcCtD
Zoledronate—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00748	CcSEcCtD
Zoledronate—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00744	CcSEcCtD
Zoledronate—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00743	CcSEcCtD
Zoledronate—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00703	CcSEcCtD
Zoledronate—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00687	CcSEcCtD
Zoledronate—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00683	CcSEcCtD
Zoledronate—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0068	CcSEcCtD
Zoledronate—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00677	CcSEcCtD
Zoledronate—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00669	CcSEcCtD
Zoledronate—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00664	CcSEcCtD
Zoledronate—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00659	CcSEcCtD
Zoledronate—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00646	CcSEcCtD
Zoledronate—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00634	CcSEcCtD
Zoledronate—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00622	CcSEcCtD
Zoledronate—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00618	CcSEcCtD
Zoledronate—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00612	CcSEcCtD
Zoledronate—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0061	CcSEcCtD
Zoledronate—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00606	CcSEcCtD
Zoledronate—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00603	CcSEcCtD
Zoledronate—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00595	CcSEcCtD
Zoledronate—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00593	CcSEcCtD
Zoledronate—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0059	CcSEcCtD
Zoledronate—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00575	CcSEcCtD
Zoledronate—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00571	CcSEcCtD
Zoledronate—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00569	CcSEcCtD
Zoledronate—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00561	CcSEcCtD
Zoledronate—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00561	CcSEcCtD
Zoledronate—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00561	CcSEcCtD
Zoledronate—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0056	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00558	CcSEcCtD
Zoledronate—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00555	CcSEcCtD
Zoledronate—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00549	CcSEcCtD
Zoledronate—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00543	CcSEcCtD
Zoledronate—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00538	CcSEcCtD
Zoledronate—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00538	CcSEcCtD
Zoledronate—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00535	CcSEcCtD
Zoledronate—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00528	CcSEcCtD
Zoledronate—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00527	CcSEcCtD
Zoledronate—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00523	CcSEcCtD
Zoledronate—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0052	CcSEcCtD
Zoledronate—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00513	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0049	CcSEcCtD
Zoledronate—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00487	CcSEcCtD
Zoledronate—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00483	CcSEcCtD
Zoledronate—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0048	CcSEcCtD
Zoledronate—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00478	CcSEcCtD
Zoledronate—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00474	CcSEcCtD
Zoledronate—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00468	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00465	CcSEcCtD
Zoledronate—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00464	CcSEcCtD
Zoledronate—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0046	CcSEcCtD
Zoledronate—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0046	CcSEcCtD
Zoledronate—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000963	0.00444	CcSEcCtD
Zoledronate—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000956	0.0044	CcSEcCtD
Zoledronate—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.00428	CcSEcCtD
Zoledronate—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.00425	CcSEcCtD
Zoledronate—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.00425	CcSEcCtD
Zoledronate—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000861	0.00397	CcSEcCtD
Zoledronate—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000839	0.00386	CcSEcCtD
Zoledronate—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000827	0.00381	CcSEcCtD
Zoledronate—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0008	0.00368	CcSEcCtD
Zoledronate—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000773	0.00356	CcSEcCtD
Zoledronate—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.00342	CcSEcCtD
Zoledronate—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00339	CcSEcCtD
Zoledronate—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000736	0.00339	CcSEcCtD
Zoledronate—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.00337	CcSEcCtD
Zoledronate—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.0032	CcSEcCtD
